Regan J Lauer is Chief Accounting Officer of ImmunityBio, Inc.. Currently has a direct ownership of 110,258 shares of IBRX, which is worth approximately $346,210. The most recent transaction as insider was on Feb 22, 2025, when has been sold 1,669 shares (Common Stock) at a price of $3.42 per share, resulting in proceeds of $5,707. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 110K
2.22% 3M change
16.88% 12M change
Total Value Held $346,210

REGAN J LAUER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2025
SELL
Payment of exercise price or tax liability
$5,707 $3.42 p/Share
1,669 Reduced 1.49%
110,258 Common Stock
Feb 22 2025
BUY
Exercise of conversion of derivative security
-
4,065 Added 3.5%
111,927 Common Stock
Dec 15 2024
SELL
Payment of exercise price or tax liability
$21,533 $2.87 p/Share
7,503 Reduced 6.5%
107,862 Common Stock
Dec 15 2024
BUY
Exercise of conversion of derivative security
-
21,031 Added 15.42%
115,365 Common Stock
Jan 31 2024
SELL
Payment of exercise price or tax liability
$45,259 $3.36 p/Share
13,470 Reduced 12.49%
94,334 Common Stock
Jan 31 2024
BUY
Exercise of conversion of derivative security
-
32,872 Added 23.37%
107,804 Common Stock
Dec 15 2023
BUY
Exercise of conversion of derivative security
-
21,030 Added 21.91%
74,932 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
-
32,872 Added 37.88%
53,902 Common Stock
Jun 15 2023
BUY
Exercise of conversion of derivative security
-
21,030 Added 50.0%
21,030 Common Stock
RJL

Regan J Lauer

Chief Accounting Officer
San Diego, CA

Track Institutional and Insider Activities on IBRX

Follow ImmunityBio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

News

Receive news related to ImmunityBio, Inc.

Track Activities on IBRX